Published: July 29, 2010
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Monsanto Company
BOCA RATON, Fla. - (BUSINESS WIRE) - Robbins Geller Rudman & Dowd LLP ("Robbins Geller" ) (http://www.rgrdlaw.com/cases/monsanto/)
today announced that a class action has been commenced on behalf of an
institutional investor in the United States District Court for the
Eastern District of Missouri on behalf of purchasers of the common stock
of Monsanto Company ("Monsanto" or the "Company" ) (NYSE:MON) between
January 7, 2009 and May 27, 2010, inclusive (the "Class Period" ),
seeking to pursue remedies under the Securities Exchange Act of 1934
(the "Exchange Act" ).
If you wish to serve as lead plaintiff, you must move the Court no later
than 60 days from today. If you wish to discuss this action or have any
questions concerning this notice or your rights or interests, please
contact plaintiff's counsel, David J. George of Robbins Geller at
800/449-4900 or 619/231-1058, or via e-mail at djr@rgrdlaw.com.
If you are a member of this Class, you can view a copy of the complaint
as filed or join this class action online at http://www.rgrdlaw.com/cases/monsanto/.
Any member of the putative class may move the Court to serve as lead
plaintiff through counsel of their choice, or may choose to do nothing
and remain an absent class member.
The complaint charges Monsanto and certain of its officers and
executives with violations of the Exchange Act. Monsanto is a provider
of agricultural products for farmers including seeds, biotechnology
trait products, and herbicides, most notably Roundup.
The complaint alleges that, throughout the Class Period, defendants
failed to disclose material adverse facts about the Company's true
financial condition, business and prospects. Specifically, the complaint
alleges that defendants failed to disclose: (i) that demand for the
Company's herbicide products was substantially declining as competition
from Chinese producers of generic glyphosate products was causing a
collapse in the prices of glyphosate products; (ii) that the Company
would be unable to maintain herbicide prices as defendants knew that
they had to cut prices significantly to be able to compete with the
avalanche of generic herbicide products that were entering the market;
and (iii) that, as a result of the foregoing, defendants' positive
statements about the Company, its earnings, prospects and financial
condition were lacking in a reasonable basis and materially misleading.
On May 27, 2010, the Company announced that it was "dramatically"
repositioning its Roundup business, lowering its full-year 2010
guidance to $2.40 to $2.60 a share from $3.10 to $3.30 a share, and
lowering its free cash flow guidance. The Company also announced that
its guidance for Roundup and other glyphosate-based products was now
$50 to $200 million, down from $600 million on April 7, 2010. On this
news, the Company's stock price fell from a price of $52.66 prior to the
announcement to close at $50.27 on extremely heavy volume.
Plaintiff seeks to recover damages on behalf of all purchasers of the
common stock of Monsanto during the Class Period (the "Class" ). The
plaintiff is represented by Robbins Geller, which has expertise in
prosecuting investor class actions and extensive experience in actions
involving financial fraud.
Robbins Geller, a 180-lawyer firm with offices in San Diego, San
Francisco, New York, Boca Raton, Washington, D.C., Philadelphia and
Atlanta, is active in major cases pending in federal and state courts
throughout the United States and has taken a leading role in many
important actions on behalf of defrauded investors, consumers, and
companies, as well as victims of human rights violations. The Robbins
Geller Web site (http://www.rgrdlaw.com)
has more information about the firm.

Robbins Geller Rudman & Dowd LLP
David J. George, 800-449-4900
djr@rgrdlaw.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News